Thus, this clinical evidence strongly indicates that the expression level of the lncRNA MIAT/HMGB1/IL6 axis is elevated in resistant NPC tumors, which is highly correlated with poor survival. This evidence concerns the gene MIAT and nasopharyngeal carcinoma.